Litcius/Paper detail

P2Y12 Inhibitor Monotherapy or Dual Antiplatelet Therapy After Complex Percutaneous Coronary Interventions

Felice Gragnano, Roxana Mehran, Mattia Branca, Anna Franzone, Usman Baber, Yangsoo Jang, Takeshi Kimura, Joo‐Yong Hahn, Qiang Zhao, Stephan Windecker, C. Michael Gibson, Byeong‐Keuk Kim, Hirotoshi Watanabe, Young Bin Song, Yunpeng Zhu, Pascal Vranckx, Shamir R. Mehta, Sung‐Jin Hong, Kenji Ando, Hyeon‐Cheol Gwon, Paolo Calabrò, Patrick W. Serruys, George Dangas, Eugène McFadden, Dominick J. Angiolillo, Dik Heg, Marco Valgimigli

2023Journal of the American College of Cardiology119 citationsDOIOpen Access PDF

Topics & Concepts

Conventional PCIMedicinePercutaneous coronary interventionInternal medicineClinical endpointCardiologyP2Y12ClopidogrelStentMyocardial infarctionRandomized controlled trialAntiplatelet Therapy and Cardiovascular DiseasesCoronary Interventions and DiagnosticsAcute Myocardial Infarction Research
P2Y12 Inhibitor Monotherapy or Dual Antiplatelet Therapy After Complex Percutaneous Coronary Interventions | Litcius